27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management

• DOI: 10.1016/j.jid.2023.09.035
• Publication Date: 2023-11-06T05:15:30Z
• Authors: J. Edelkamp; T. Rouille; J.H. Kim; A. Keren; J. Viola-Söhnlein; L. Gao; A. Rossi; F. Jimenez; A. Gilhar; R. Paus; I.M. Catlett; M. Bertolini